Login

Tomorrow's Company interviews Roger Parry CBE, Chairman of YouGov plc and Oxford Metrics plc, as well as Peter Taylor. 00:10:00

Share On Facebook Share On Twitter

Imogen Moorhouse is CEO/Exec Dir at Oxford Metrics PLC. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Hannah's Children: Defying Birth and Tradition|Catherine Pakaluk,Professor,Hannah's Children
00:10:00
Flagstone FM's Investment Principles | DANIEL STOUS - SHAREHOLDER & LEAD WEALTH ADVISOR of Flagstone Financial Management
00:10:00
Frontier Diamonds: South African Mines Expansion and Innovative Diamond Recovery
00:10:00
World-class Athlete Entrepreneur and Partner Upfront Ventures|Kobie Fuller,General Partner,Upfront Ventures
00:10:00
Exploring Science and AI investing|Josh Wolfe,Founder, Managing Director,Lux Capital
00:10:00
Equity Strategist Tom Sartor about their current project, with two assets now in production, as well as their thoughts on the energy| Nick Jorss , Chairman,BOWEN COKING COAL LIMITED
00:10:00
Retirement Planning with Michael Kitces | Michael Kitces - Renowned Financial Planner and Educator
00:10:00
Discover develop and deliver innovative therapies for the treatment of advanced solid tumors and other major diseases|David J. Mazzo,President,Caladrius Biosciences Inc
00:10:00
leading seed rounds for visionary B2B SaaS startups in the fastest growing, most promising venture capital|William Leonard,Investor,Valor Ventures
00:10:00
ACCO Brands Corporation Webcast Presentation Lytham Partners Spring 2022 Investor Conference | Boris Elisman, CEO , ACCO Brand.
00:10:00
Long-Term Investments, Innovation, and Overcoming Market Challenges: Kinnevik’s CEO Georgi Ganev and Chair James Anderson on Sustainable Growth
00:10:00
Orlando Bravo: Transforming Innovators into Market Leaders | Orlando Bravo - founder and managing partner of Thoma Bravo

© 2017 - Neuhu+